Individual Bioequivalence Revisited

By Chen M-L.  

Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. : 701-706

Adis International

Access to resources Recommend Favorite

Predictive Molecular Markers: Has the Time Come for Routine Use in Lung Cancer?

By Davies Angela M.   Mack Philip C.   Lara Primo N.   Lau Derick H.   Danenberg Kathleen   Gumerlock Paul H.   Gandara David R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 2, 2004-03 ,pp. : 125-131

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacogenetics: Has the Time Come for Pharmacists to Embrace and Implement the Science?

By Beier Manju   Panchapagesan Madhumitha   Carman Ladd  

The Consultant Pharmacist, Vol. 28, Iss. 11, 2013-11 ,pp. : 696-711

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Integrating Pharmacogenetics for Assessment of Herb-Drug Interactions: Has the Time Come?

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 3, 2012-09 ,pp. : 247-253

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science)

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 1, 2012-03 ,pp. : 7-15

Bentham Science Publishers

Access to resources Recommend Favorite